Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Analyses of human vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigens

Frontiers in Immunology(2024)10.3389/fimmu.2023.1193079Source: DataRank Database

Analyses of human vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigens is a research paper published in Frontiers in Immunology (2024). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

Linked data & code

gen uniprot nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 4.06)OA: goldTopics (42)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (21)

Sarah E. Silk ORCID,Catherine Mkindi ORCID,Karolina M. Kwiatkowska ORCID,Mimi M. Hou ORCID,Amelia M. Lias ORCID

Live enrichment

PubMed:38299155 PMC:PMC10827869 OpenAlex:https://openalex.org/W4390953058

European & Developing Countries Clinical Trials Partnership (EDCTP)

Grant: RIA2016V-1649

Wellcome Trust

Grant: 106917/Z/15/Z

Wellcome Trust

Grant: 209200/Z/17/Z

Wellcome Trust

Grant: 212336/Z/18/Z

Medical Research Council

Grant: G1100086

Wellcome Trust

FWCI

4.06

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.3389/fimmu.2023.1193079

publisherhttps://doi.org/10.3389/fimmu.2023.1193079

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1193079/full

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38299155

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10827869

Fields of Study

Malaria Research and ControlComplement system in diseasesMosquito-borne diseases and controlHumansPlasmodium falciparumBone MarrowAntigens, ProtozoanVaccinesAdjuvants, ImmunologicMalaria, VivaxImmunoglobulin G

MeSH Terms

Adjuvants, ImmunologicAntigens, ProtozoanBone MarrowHumansImmunoglobulin GPlasmodium falciparumVaccinesMalaria, Vivax

Keywords

AdjuvantImmunogenicityImmunologyMalaria vaccineELISPOTMalariaPlasmodium vivaxMedicineBooster dosePlasmodium falciparumVirologyAntigenBone marrowCircumsporozoite proteinBiologyCD8ImmunizationT cellsAntibodyPlasma cellsB cellsMemory B CellsVaccine Dosing Regimen

Sustainable Development Goals

SDG 0: Good health and well-being

Analyses of human vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigens

FAIR Checklist

Authors (21)

Funding (7 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)